PAX5 alterations in B-cell acute lymphoblastic leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1023606
Abstract: PAX5, a master regulator of B cell development and maintenance, is one of the most common targets of genetic alterations in B-cell acute lymphoblastic leukemia (B-ALL). PAX5 alterations consist of copy number variations (whole gene,… read more here.
Keywords: pax5; leukemia; pax5 alterations; alterations cell ... See more keywords